Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

[131I]-Basiliximab is safe and induces responses in patients with refractory lymphoma

Jan. 7, 2010

INCB-7839 improves response to trastuzumab in metastatic HER2+ breast cancer

Jan. 7, 2010

Chinese scientists describe novel compounds for cancer treatment

Jan. 5, 2010

Janssen presents protein kinase inhibitors for cancer therapy

Jan. 5, 2010

MethylGene describes tyrosine kinase inhibitors for the treatment of proliferative diseases

Jan. 5, 2010

Janssen discloses novel HDAC inhibitors for cancer treatment

Jan. 5, 2010

Swiss scientists present novel BB2 antagonists for cancer diagnosis and treatment

Jan. 5, 2010

FDA approves Takeda's sNDA for Velcade for first-line treatment of multiple myeloma

Jan. 5, 2010

First-in-man study of EMD-1214063 initiated in patients with solid tumors

Jan. 5, 2010

Adventrx submits NDA to FDA for ANX-530

Jan. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...